Le Japon autorise l'utilisation du vaccin Pfizer

Le Japon autorise l'utilisation du vaccin Pfizer © Reuters. LE JAPON AUTORISE L'UTILISATION DU VACCIN PFIZER

TOKYO (Reuters) - Le ministère japonais de la Santé a officiellement approuvé dimanche l'utilisation du vaccin contre le COVID-19 de Pfizer (NYSE:) et BioNTech, le premier autorisé dans l'archipel.

Le Japon, où résident 126 millions de personnes, a signé des contrats avec plusieurs laboratoires - AstraZeneca (LON:), Moderna et Pfizer - pour se procurer plus de 300 millions de doses de vaccin.

(Kiyoshi Takenaka et Elaine Lies; version française Jean-Stéphane Brosse)

Responsabilité: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Let's block ads! (Why?)